Millennium Management Reports 3.2% Stake in Forte Biosciences, Inc. (FBRX)

On July 15, 2026, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander filed a Schedule 13G/A with the SEC, reporting a combined beneficial ownership of 655,199 shares of Forte Biosciences, Inc. (FBRX) common stock. This represents a 3.2% ownership stake in the company as of the event date on June 30, 2026. This filing marks an increase from a previously reported 0.0% position, indicating a new significant holding for the group. The reporting persons share voting and dispositive power over the shares, which are held by various entities under their investment discretion. The filing includes a joint filing agreement and a certification that the shares were not acquired with the intent to change or influence the control of the issuer. Because the ownership percentage is below the 5% threshold typically required for active reporting, this filing serves to update the market on Millennium's position in the clinical-stage biopharmaceutical company.